Back
Day Range
$196.74
$201.87
52-Week Range
$125.38
$256.36
Volume
853,831
50D / 200D Avg
$216.00
/
$191.28
Prev Close
$195.28
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -136.2 | 0.4 |
| P/B | 16.6 | 2.9 |
| ROE % | -14.3 | 3.8 |
| Net Margin % | -9.0 | 3.9 |
| Rev Growth 5Y % | 38.6 | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
Hold
$249.57
+24.7%
Low: $172.00
High: $285.00
Forward EPS
-$1.81
Est. Revenue
2.7 B
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$4.28
$4.18 – $4.44
|
5 B | 5 |
| FY2029 |
$1.78
$1.73 – $1.84
|
4.4 B | 11 |
| FY2028 |
$1.04
-$1.15 – $3.73
|
3.8 B | 13 |
Key Takeaways
Revenue grew 38.57% annually over 5 years — strong growth
Debt/Equity of 0.13 — conservative balance sheet
Generating 109.11M in free cash flow
Capital efficient — spends only 4.60% of revenue on capex
Growth
Revenue Growth (5Y)
38.57%
Revenue (1Y)35.90%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-14.32%
ROIC-12.06%
Net Margin-9.03%
Op. Margin-13.44%
Safety
Debt / Equity
0.13
Current Ratio3.39
Interest Coverage-76.16
Valuation
P/E Ratio
-136.24
P/B Ratio16.56
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 35.90% | Revenue Growth (3Y) | 45.95% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 38.57% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 2.31B | Net Income (TTM) | -208.16M |
| ROE | -14.32% | ROA | -8.30% |
| Gross Margin | 64.85% | Operating Margin | -13.44% |
| Net Margin | -9.03% | Free Cash Flow (TTM) | 109.11M |
| ROIC | -12.06% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.13 | Current Ratio | 3.39 |
| Interest Coverage | -76.16 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -136.24 | P/B Ratio | 16.56 |
| P/S Ratio | 12.30 | PEG Ratio | 230.22 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 28.36B | Enterprise Value | 27.50B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2.31B | 1.70B | 1.08B | 820.22M | 625.49M |
| Net Income | -208.16M | -190.43M | -434.80M | -547.80M | -471.72M |
| EPS (Diluted) | -1.52 | -1.53 | -3.78 | -5.57 | -5.21 |
| Gross Profit | 1.50B | 1.02B | 492.74M | 363.97M | 307.07M |
| Operating Income | -309.91M | -222.29M | -446.25M | -541.04M | -468.17M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 2.51B | 1.66B | 1.44B | 1.39B | 1.24B |
| Total Liabilities | 795.62M | 465.32M | 676.37M | 688.73M | 583.18M |
| Shareholders' Equity | 1.71B | 1.20B | 765.33M | 705.74M | 653.30M |
| Total Debt | 214.38M | 187.12M | 441.99M | 446.22M | 397.23M |
| Cash & Equivalents | 1.08B | 945.59M | 642.10M | 466.09M | 84.39M |
| Current Assets | 1.50B | 1.38B | 1.26B | 1.21B | 1.09B |
| Current Liabilities | 441.23M | 344.05M | 307.27M | 310.50M | 218.96M |